ADVFN US – Market Content Editor

Manufacturing progress, stability data, and formulation advances are moving Lakewood-Amedex’s lead antimicrobial candidate closer to Phase 2 testing in infected diabetic foot ulcers. Key Investor Takeaways Why LABT Stock Is in Focus Lakewood-Amedex Biotherapeutics announced positive development and manufacturing data for Nu-3, its lead antimicrobial candidate targeting mildly infected diabetic foot ulcers. According to the…

A new robotics-focused partnership could broaden Nature’s Miracle’s exposure to AI automation, industrial robotics, and smart infrastructure markets beyond its core controlled-environment agriculture business. Key Investor Takeaways Why Nature’s Miracle Holding Stock Is in Focus Nature’s Miracle Holding announced that it signed a Memorandum of Understanding with DROMNI Intelligence Technology to collaborate on autonomous robotics…

A new preclinical research agreement positions Clearmind Medicine to evaluate whether MEAI could complement or extend the effects of blockbuster GLP-1 obesity therapies such as tirzepatide. Key Investor Takeaways Why Clearmind Medicine Stock Is in Focus Clearmind Medicine announced a new research agreement with Yissum Research Development Company of the Hebrew University of Jerusalem to…

Brenmiller Energy’s leadership transition comes as the company increases its focus on scaling thermal energy storage commercialization and industrial decarbonization solutions. Key Investor Takeaways Why Brenmiller Energy Stock Is in Focus Brenmiller Energy announced that its board appointed Nir Brenmiller as Chief Executive Officer, replacing Avi Brenmiller in the CEO role while Avi remains Chairman…

Strong charter rates, rising cash flow, and expanding exposure to the product tanker market pushed C3is to sharply higher adjusted earnings in the first quarter of 2026. Key Investor Takeaways Why C3is Stock Is in Focus C3is reported first-quarter 2026 revenue of $11.6 million, up 34% from the prior-year period, while adjusted net income climbed…

A newly developed immortalized silkworm silk gland cell line could broaden Kraig Biocraft Laboratories’ reach beyond spider silk textiles into recombinant proteins, therapeutics, and industrial biotechnology applications. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Biocraft Laboratories announced that its research team successfully developed an immortalized silk gland cell line, which the company…

A multi-week national radio hosting role for Brig. Gen. Blaine Holt could increase visibility for Xeriant’s technology and defense-focused positioning as the company continues promoting its advanced materials strategy. Key Investor Takeaways Why Xeriant Stock Is in Focus Xeriant announced that Brig. Gen. Blaine Holt (ret.), President of the company’s Factor X Research Group, will…

As the world accelerates toward renewable energy, advanced technology, and modern defense systems, one challenge is becoming impossible to ignore: the growing demand for critical minerals. Hidden beneath the surface of everyday life, these resources power everything from electric vehicles and solar panels to smartphones, aircraft, and military infrastructure. This trailer offers a first look…

Stock Moves Higher Following Strategic Deal Announcement Shares of York Space Systems (NYSE:YSS) climbed 8.1% in premarket trading on Monday after the company announced a definitive agreement to acquire ALL.SPACE, a satellite communications and multi-network connectivity technology provider. The transaction represents York’s second major strategic acquisition since becoming publicly listed on the New York Stock…

Stock Jumps Following AI Infrastructure Expansion Announcement Shares of HIVE Digital Technologies (NASDAQ:HIVE) soared 33.1% in premarket trading on Monday after the company unveiled plans to develop a large-scale artificial intelligence infrastructure facility in the Greater Toronto Area. The project will be led through HIVE subsidiary BUZZ High Performance Computing Inc., which has acquired approximately…